Online Only Articles

E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy

Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Royal Liverpool University Hospital, UK
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London
Vol. 102 No. 8 (2017): August, 2017 https://doi.org/10.3324/haematol.2017.168740